Management of Abnormal Thyroid Nodules

Initial Diagnostic Approach

The American College of Endocrinology recommends ultrasound-guided fine-needle aspiration biopsy (FNAB) for risk stratification of abnormal thyroid nodules, with surgery as the first-line treatment for malignant or suspicious nodules, and thermal ablation considered for select benign symptomatic nodules or low-risk papillary thyroid cancers 1
The American Thyroid Association suggests that all patients with thyroid nodules require ultrasound-guided FNAB to confirm pathological diagnosis before determining the management pathway, which is the most accurate and cost-effective method for evaluating thyroid nodules 1, 2

The American Association of Clinical Endocrinologists recommends that most benign thyroid nodules require no treatment and should undergo surveillance, with treatment indications including nodules causing compression symptoms, nodules ≥2cm with gradual enlargement, cosmetic concerns, and autonomously functioning nodules causing hyperthyroidism 5, 6, 1
The Society of Surgical Oncology states that surgery remains the treatment of choice for nodules with malignant or suspicious cytology, with the extent of surgery depending on postoperative risk stratification using the American Thyroid Association's low-, intermediate-, and high-risk classification system 7, 2, 1

The International Society of Endocrine Surgery recommends that thermal ablation may be considered for very specific papillary thyroid cancers meeting strict criteria, including single nodule with maximal diameter ≤1cm, classical variant papillary thyroid carcinoma confirmed by biopsy, and no invasion of trachea, large blood vessels, or perithyroid structures 5, 7, 8, 1
The European Society of Endocrinology suggests that following thermal ablation of malignant nodules, TSH suppression therapy is mandatory, with target TSH 0.5-2.0 mU/L for absolute indications and target TSH <0.5 mU/L for relative indications 8, 5, 1

The American Thyroid Association recommends regular surveillance for all thyroid nodules regardless of treatment approach, with initial ultrasound surveillance at 12-month intervals for untreated nodules and first follow-up at 1 month for treated nodules (post-ablation) 8, 5, 3, 6, 2, 1